Hyperpigmentation is a common skin condition where patches of skin become darker than the surrounding area. It happens when cells in your skin produce too much melanin, the pigment that gives skin its color. It’s not a disease on its own but rather a visible result of various triggers, from sun exposure and hormonal shifts to inflammation and certain medications. In most cases, hyperpigmentation is harmless, though it can sometimes signal an underlying health issue worth investigating.
How Excess Pigment Forms
Your skin contains specialized cells called melanocytes that produce melanin. Each melanocyte connects to 30 to 40 surrounding skin cells through tiny branches, delivering packets of pigment that position themselves over cell nuclei like tiny umbrellas, shielding DNA from ultraviolet damage. This system is tightly regulated. When something disrupts it, whether UV radiation, hormones, or inflammation, pigment production ramps up and dark patches appear.
The key enzyme driving this process is tyrosinase, a copper-dependent protein that controls the rate-limiting step of melanin production. When UV light hits your skin, it triggers a chain reaction at the cell membrane that ultimately activates tyrosinase, resulting in more melanin. Hormones like ACTH (the stress hormone your pituitary gland releases) and alpha-MSH also stimulate melanocytes directly, which explains why conditions like Addison’s disease or pregnancy can cause widespread darkening.
The Three Most Common Types
Not all dark patches are the same. The type you’re dealing with determines how it behaves and how well it responds to treatment.
Melasma produces brown or blue-gray patches, typically on the face and arms. It’s driven primarily by hormonal changes, which is why it often appears during pregnancy, while taking oral contraceptives, or during hormone therapy. Sun exposure makes it worse, and it tends to be stubborn and recurring.
Post-inflammatory hyperpigmentation (PIH) is darkening that lingers after your skin heals from an injury or inflammation. Acne, eczema, psoriasis, burns, and even aggressive cosmetic treatments can all leave behind discolored patches. The skin looks noticeably darker where the original lesion was, and this can persist for months or longer depending on depth.
Solar lentigines, commonly called age spots or sun spots, develop from cumulative UV exposure over years. They become increasingly common after age 40, as the melanocytes that remain in aging skin tend to grow larger and become more active in areas that have absorbed the most sun.
Who Gets It and Why Skin Tone Matters
Hyperpigmentation can affect anyone, but it disproportionately impacts people with medium to deep skin tones. A study examining prevalence across skin types found that 81.8% of individuals with medium-brown skin (Fitzpatrick type IV) had some form of hyperpigmentation, followed by 77% of those with the deepest skin tones and 47.2% of those with dark brown skin. The pattern is clear: higher baseline melanin activity and a more robust inflammatory pigment response make darker skin types significantly more vulnerable.
This is especially relevant for post-inflammatory hyperpigmentation. A pimple or minor cut that fades without a trace on lighter skin can leave a dark mark lasting months on deeper skin tones.
Common Triggers Beyond Sun Exposure
UV radiation is the single biggest driver of hyperpigmentation, but it’s far from the only one. Hormonal fluctuations are a major factor: oral contraceptives stimulate melanocytes directly, and the hormonal surges of pregnancy are notorious for triggering melasma. Conditions that elevate ACTH levels, such as Addison’s disease or certain pituitary tumors, cause widespread darkening, particularly in sun-exposed areas.
Medications are another underrecognized cause. Drug-induced pigmentation has been linked to a surprisingly long list of pharmacologic classes, including certain antibiotics (particularly tetracyclines), antidepressants, anti-seizure drugs, antimalarials like hydroxychloroquine, chemotherapy agents, and even common anti-inflammatory drugs. Some medications make your skin more sensitive to UV light, leading to superficial burns that trigger post-inflammatory darkening. Others stimulate melanocytes directly or alter hormone levels in ways that increase pigment production. If you’ve noticed new dark patches after starting a medication, the connection is worth raising with your prescriber.
Epidermal vs. Dermal Pigment
One of the most important distinctions in hyperpigmentation is how deep the excess melanin sits. Epidermal hyperpigmentation, where the extra pigment is in the outer layer of skin, appears tan to dark brown and can take months to years to resolve on its own without treatment. Dermal hyperpigmentation, where pigment has dropped into the deeper skin layer, looks blue-gray. It can be permanent or take an extremely long time to fade, if it fades at all.
This depth determines your treatment options. Topical products can reach epidermal pigment effectively but have limited ability to address pigment trapped in the dermis. Knowing which type you have helps set realistic expectations for how quickly you’ll see results.
Topical Treatments That Work
Hydroquinone at 4% concentration remains the gold standard topical treatment for hyperpigmentation, particularly melasma. It works by inhibiting tyrosinase, the enzyme that drives melanin production. It’s effective, but it can cause irritation, and it’s actually banned for over-the-counter sale in the European Union due to safety concerns with long-term use.
For people who can’t tolerate hydroquinone or prefer alternatives, combinations of niacinamide, tranexamic acid, and vitamin C have shown promising results. In a clinical trial, a serum containing 5% niacinamide, 1% tranexamic acid, and 0.2% stabilized vitamin C reduced melanin density comparably to 4% hydroquinone over five months. Hydroquinone worked faster initially (46.4% improvement at three months compared to 23%), but by the five-month mark, the difference was no longer statistically significant. The non-hydroquinone serum also had better tolerability and patient satisfaction, making it a viable option for sensitive skin.
Tranexamic acid has emerged as a particularly noteworthy ingredient. Oral tranexamic acid at doses of 250 to 500 mg twice daily has shown 49% to 95% improvement in melasma severity scores over 8 to 24 weeks, with side effects generally limited to mild digestive discomfort. Topical formulations at 2% to 5% concentration have shown comparable results to hydroquinone with fewer irritant reactions, and visible improvement often begins by week four to eight.
Chemical Peels for Deeper Results
When topical products aren’t enough, chemical peels offer a more aggressive approach. The right peel depends on the type and depth of pigmentation.
Superficial peels using salicylic acid (20 to 30%), glycolic acid (30 to 40%), or low-concentration trichloroacetic acid (10 to 20%) work well for post-inflammatory hyperpigmentation and mild melasma. A series of five salicylic acid peels at two-week intervals, combined with hydroquinone, produced moderate to significant improvement in 66% of patients with deep skin tones. Medium-depth peels using higher concentrations of trichloroacetic acid (35%) or combination formulas can address solar lentigines and more stubborn pigmentary disorders.
For melasma specifically, tretinoin peels at 1% concentration have performed as well as 70% glycolic acid peels in darker skin tones. Adding 5% topical ascorbic acid to a 20% trichloroacetic acid peel proved superior to the peel alone for epidermal melasma. The key takeaway is that peels work best as part of a broader treatment plan that includes sun protection and maintenance topicals.
Why Standard Sunscreen Isn’t Enough
Visible light, the light you can see with your eyes, makes up 45% of the sunlight spectrum and can trigger skin darkening and worsen pigmentation disorders, especially in darker skin tones. This is a problem because standard UV-blocking sunscreens, even those rated SPF 50+, don’t protect against visible light.
A clinical study found that adding iron oxide to a sunscreen routine made a meaningful difference for melasma. After 12 weeks, 36% of melasma participants using SPF 50 plus iron oxide showed superior improvement in skin radiance compared to 0% in the group using SPF 50 alone. Iron oxide is the ingredient that gives tinted sunscreens their color, so if you’re treating hyperpigmentation, switching to a tinted sunscreen formulated with iron oxide provides a layer of protection that clear sunscreens simply cannot offer.
When a Dark Spot Needs Medical Attention
Most hyperpigmentation is cosmetic, but some dark spots warrant prompt evaluation. The American Academy of Dermatology’s ABCDE framework helps distinguish benign pigmentation from potentially dangerous changes. Look for asymmetry (one half doesn’t match the other), irregular or scalloped borders, color variation within a single spot (mixing shades of tan, brown, black, white, red, or blue), diameter larger than 6 millimeters (roughly the size of a pencil eraser), and evolution, meaning any spot that’s changing in size, shape, or color over time. A spot that’s itching or bleeding also deserves a closer look.
Widespread or unexplained hyperpigmentation, particularly if it appears suddenly in sun-exposed areas, can also point to hormonal disorders or medication side effects that need investigation beyond skin-level treatment.